Ranbaxy

Dalal Street’s Suryanamaskar Explained

Shailendra Tyagi

Sun’s bet is that it can fix the factory glitches, get US regulatory clearances, and turn the Sun-Ranbaxy combine into a low-cost generics export powerhouse.

The Art of Letting Go

Sourav Majumdar

Indian business groups are learning to separate emotion from valuation. For shareholders, this can only be a good sign.

Burning Cash to Bust Those Blocks

Ninad D. Sheth

The Indian pharma gameplan appears more like irrational overreach and less like an achievement

Magazine

Subscribe today and save up to 85% off the cover price

Subscribe Now

Ranbaxy

Dalal Street’s Suryanamaskar Explained

The Art of Letting Go

Burning Cash to Bust Those Blocks

MOst Popular

Why Britain Is Broke

Lawrence Bishnoi: The New Don

Return of the Brotherhood

‘There was a whole world in the ancient caves in the Deccan,’ says William Dalrymple

Cowboys and Indians

Open

Regulars

Features

Salon

OPEN AVENUES